These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16174101)

  • 1. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
    Cretney E; McQualter JL; Kayagaki N; Yagita H; Bernard CC; Grewal IS; Ashkenazi A; Smyth MJ
    Immunol Cell Biol; 2005 Oct; 83(5):511-9. PubMed ID: 16174101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
    Dadey RE; Grebinoski S; Zhang Q; Brunazzi EA; Burton A; Workman CJ; Vignali DAA
    Immunohorizons; 2021 Jan; 5(1):48-58. PubMed ID: 33483333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
    Prinz-Hadad H; Mizrachi T; Irony-Tur-Sinai M; Prigozhina TB; Aronin A; Brenner T; Dranitzki-Elhalel M
    J Neuroinflammation; 2013 Mar; 10():36. PubMed ID: 23497038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.
    Mir S; Ali F; Chauhan D; Arora R; Khan HA
    Metab Brain Dis; 2016 Apr; 31(2):299-309. PubMed ID: 26477945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo2L/TRAIL and immune regulation.
    Anel A; Bosque A; Naval J; Pineiro A; Larrad L; Alava MA; Martinez-Lorenzo MJ
    Front Biosci; 2007 Jan; 12():2074-84. PubMed ID: 17127445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
    Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
    J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
    Aktas O; Smorodchenko A; Brocke S; Infante-Duarte C; Schulze Topphoff U; Vogt J; Prozorovski T; Meier S; Osmanova V; Pohl E; Bechmann I; Nitsch R; Zipp F
    Neuron; 2005 May; 46(3):421-32. PubMed ID: 15882642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APO2L/TRAIL: new insights in the treatment of autoimmune disorders.
    Anel A; Martinez-Lostao L
    Recent Pat Inflamm Allergy Drug Discov; 2011 Sep; 5(3):184-99. PubMed ID: 21827400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
    Terényi N; Nagy N; Papp K; Prechl J; Oláh I; Erdei A
    Mol Immunol; 2009 Nov; 47(1):57-63. PubMed ID: 19201476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.
    Razmara M; Hilliard B; Ziarani AK; Murali R; Yellayi S; Ghazanfar M; Chen YH; Tykocinski ML
    Am J Pathol; 2009 Feb; 174(2):460-74. PubMed ID: 19147815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
    Jin H; Yang R; Fong S; Totpal K; Lawrence D; Zheng Z; Ross J; Koeppen H; Schwall R; Ashkenazi A
    Cancer Res; 2004 Jul; 64(14):4900-5. PubMed ID: 15256461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M; Labrinidis A; Hay S; Liapis V; Bouralexis S; Welldon K; Coventry BJ; Findlay DM; Evdokiou A
    Cancer Res; 2006 May; 66(10):5363-70. PubMed ID: 16707463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).
    Ravi R; Bedi A
    Cancer Res; 2002 Mar; 62(6):1583-7. PubMed ID: 11912124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.